Literature DB >> 23007163

Decreased miR-7 expression in the skin and sera of patients with dermatomyositis.

Yuka Oshikawa1, Masatoshi Jinnin, Takamitsu Makino, Ikko Kajihara, Katsunari Makino, Noritoshi Honda, Wakana Nakayama, Kuniko Inoue, Satoshi Fukushima, Hironobu Ihn.   

Abstract

Expression of microRNA (miRNA) in the skin in dermatomyositis has not previously been studied in detail. In this study, we performed miRNA array analysis using miRNAs purified from dermatomyositis-involved skin and normal skin, and found that several miRNAs were up- or down-regulated in dermatomyositis skin. Among them, we focused on miR-7, one of the most down-regulated miRNAs in dermatomyositis skin. Total miRNAs were purified from serum, and hsa-miR-7 levels were measured with quantitative real-time PCR using the specific primer. Serum levels of miR-7 were significantly decreased in patients with dermatomyositis compared with normal subjects or patients with other autoimmune diseases. Thus, serum miR-7 levels might be a possible diagnostic marker for dermatomyositis. Clarifying the up- or down-stream events of down-regulated miR-7 in patients with dermatomyositis may lead to further understanding of the disease and a new therapeutic approach.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23007163     DOI: 10.2340/00015555-1459

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  8 in total

Review 1.  Epigenetics in Non-tumor Immune-Mediated Skin Diseases.

Authors:  M C Ovejero-Benito; E Daudén; Alejandra Reolid; E Muñoz-Aceituno; F Abad-Santos
Journal:  Mol Diagn Ther       Date:  2021-03-01       Impact factor: 4.074

2.  [Advances in epigenetic markers of dermatomyositis/polymyositis].

Authors:  Y Y Yang; X X Zuo; H L Zhu; S J Liu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-04-18

3.  U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis.

Authors:  Fabian Benz; Christoph Roderburg; David Vargas Cardenas; Mihael Vucur; Jérémie Gautheron; Alexander Koch; Henning Zimmermann; Jörn Janssen; Lukas Nieuwenhuijsen; Mark Luedde; Norbert Frey; Frank Tacke; Christian Trautwein; Tom Luedde
Journal:  Exp Mol Med       Date:  2013-09-20       Impact factor: 8.718

4.  MicroRNA and mRNA profiling in the idiopathic inflammatory myopathies.

Authors:  Joanna E Parkes; Anastasia Thoma; Adam P Lightfoot; Philip J Day; Hector Chinoy; Janine A Lamb
Journal:  BMC Rheumatol       Date:  2020-06-10

5.  Specific Autoantibodies and Clinical Phenotypes Correlate with the Aberrant Expression of Immune-Related MicroRNAs in Dermatomyositis.

Authors:  Lifang Ye; Yu Zuo; Hanbo Yang; Wenli Li; Qinglin Peng; Xin Lu; Guochun Wang; Xiaoming Shu
Journal:  J Immunol Res       Date:  2019-02-19       Impact factor: 4.818

6.  Predicted overlapping microRNA regulators of acetylcholine packaging and degradation in neuroinflammation-related disorders.

Authors:  Bettina Nadorp; Hermona Soreq
Journal:  Front Mol Neurosci       Date:  2014-02-10       Impact factor: 5.639

7.  17β-estradiol ameliorates age-associated loss of fibroblast function by attenuating IFN-γ/STAT1-dependent miR-7 upregulation.

Authors:  Adam C Midgley; Glyn Morris; Aled O Phillips; Robert Steadman
Journal:  Aging Cell       Date:  2016-03-02       Impact factor: 9.304

8.  Neutrophil extracellular traps activate lung fibroblast to induce polymyositis-related interstitial lung diseases via TLR9-miR-7-Smad2 pathway.

Authors:  Sigong Zhang; Xueqin Jia; Qiuyue Zhang; Li Zhang; Jing Yang; Caihong Hu; Junnian Shi; Xiao Jiang; Jinyue Lu; Haili Shen
Journal:  J Cell Mol Med       Date:  2019-12-10       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.